Company Filing History:
1 out of 11 
1 out of 1,390 Years Active: 1997-2003
Title: Innovations of Gregory G. Mahairas: Advancements in Vaccine Development
Introduction
Gregory G. Mahairas, an accomplished inventor based in Seattle, WA, has made significant contributions to the field of immunology through his innovative research. With two registered patents to his name, he has developed groundbreaking solutions aimed at enhancing vaccine efficacy and distinguishing between pathogenic and non-pathogenic mycobacteria, making strides in disease prevention and treatment.
Latest Patents
Mahairas' latest inventions include a Vaccine Adjuvant and a method for creating Virulence-Attenuating Genetic Deletions from Mycobacterium BCG. The Vaccine Adjuvant patent focuses on fusion agents such as fusion proteins designed to bolster cellular immune responses (specifically Th1 type) against diseases. This patent encompasses nucleic acids that encode these fusion proteins, alongside the vectors and cells that contain them, highlighting the comprehensive approach to therapeutic advancements.
His second patent addresses specific genetic deletions that confer an avirulent phenotype to Mycobacterium BCG. This innovation facilitates the identification of phenotypic markers that help differentiate between disease-causing and non-disease-causing mycobacteria, providing valuable insights for both research and clinical applications.
Career Highlights
Throughout his career, Gregory G. Mahairas has worked with notable institutions like Pathogenesis Corporation and the Iowa State University Research Foundation, Inc. His endeavors in these organizations have fostered collaborative environments conducive to the advancement of medical research and innovation.
Collaborations
In his professional journey, Mahairas has collaborated with esteemed colleagues, notably Charles K. Stover and F. Chris Minion. These collaborations have undoubtedly enriched his research experience and contributed to the successful development of his patentable inventions.
Conclusion
Gregory G. Mahairas stands out as a significant figure in the domain of vaccine innovation and mycobacterial research. His contributions through patented inventions not only enhance our understanding of immune response but also pave the way for future therapeutic developments. As the landscape of medical research continues to evolve, inventors like Mahairas remain central to driving innovations that address pressing health challenges.